NCT05208931View on ClinicalTrials.gov

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions

Neovascular Age-related Macular Degeneration

Interventions

PROCEDURE

Anti-vascular endothelial growth factor therapy

0.05 ml anti-VEGF, intravitreal, monthly

Trial Locations (1)

350012

The S.N. Fyodorov Eye Microsurgery State Institution, Krasnodar

All Listed Sponsors

lead

The S.N. Fyodorov Eye Microsurgery State Institution

OTHER_GOV

NCT05208931 - Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence | Biotech Hunter | Biotech Hunter